Genetically engineered, live, attenuated vaccines protect nonhuman primates against aerosol challenge with a virulent IE strain of Venezuelan equine encephalitis virus

Vaccine

Volumn 23, Issue 24, 2005, Pages 3139-3147

  Reed, Douglas S ^a   Lind, Cathleen M ^a   Lackemeyer, Matthew G ^a   Sullivan, Lawrence J ^a   Pratt, William D ^a   Parker, Michael D ^a  

^a UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES   (United States)

Author keywords

Nonhuman primates; Vaccines; Venezuelan equine encephalitis virus (VEEV)

Indexed keywords

COMPLEMENTARY DNA; ENCEPHALITIS VACCINE; FURIN; IE 1009; IE 1150K; LIVE VACCINE; NEUTRALIZING ANTIBODY; UNCLASSIFIED DRUG; V 3526; VIRUS ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ARTICLE; CONTROLLED STUDY; DELETION MUTANT; DRUG EFFECT; ENCEPHALITIS VIRUS; ENCEPHALOMYELITIS; FEMALE; GENETIC ENGINEERING; MACACA; MALE; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; VACCINATION REACTION; VENEZUELAN EQUINE ENCEPHALOMYELITIS ALPHAVIRUS; VIRUS STRAIN; VIRUS VIRULENCE; WILD TYPE;

EID: 17044362650     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2004.12.023     Document Type: Article

References (25)

1. S.C. Weaver, L.A. Bellew, and R. Rico-Hesse Phylogenetic analysis of alphaviruses in the Venezuelan equine encephalitis complex and identification of the source of epizootic viruses Virology 191 1 1992 282 290
2. T.F. Tsai Arboviral infections in the United States Infect Dis Clin North Am 5 1 1991 73 102
3. A.M. Powers, M.S. Oberste, and A.C. Brault Repeated emergence of epidemic/epizootic Venezuelan equine encephalitis from a single genotype of enzootic subtype ID virus J Virol 71 9 1997 6697 6705
4. Smith JF, Davis K, Hart MK, Ludwig GV, McClain DJ, Parker MD, et al. Viral encephalitides. In: Sidwell RW, Takafuji ET, Franz DR, editors. Medical aspects of chemical and biological warfare, vol. I. Washington, DC: Office of the Surgeon General; 1997, p. 561-90.
5. P.R. Pittman, R.S. Makuch, J.A. Mangiafico, T.L. Cannon, P.H. Gibbs, and C.J. Peters Long-term duration of detectable neutralizing antibodies after administration of live-attenuated VEE vaccine and following booster vaccination with inactivated VEE vaccine Vaccine 14 4 1996 337 343
6. M.K. Hart, W. Pratt, F. Panelo, R. Tammariello, and M. Dertzbaugh Venezuelan equine encephalitis virus vaccines induce mucosal IgA responses and protection from airborne infection in BALB/c, but not C3H/HeN mice Vaccine 15 4 1997 363 369
7. N.L. Davis, K.W. Brown, G.F. Greenwald, A.J. Zajac, V.L. Zacny, and J.F. Smith Attenuated mutations of Venezuelan equine encephalitis virus containing lethal mutations in the PE2 cleavage signal combined with a second-site suppressor mutation in E1 Virology 212 1995 102 110
8. G.V. Ludwig, M.J. Turell, and P. Vogel Comparative neurovirulence of attenuated and non-attenuated strains of Venezuelan equine encephalitis virus in mice Am J Trop Med Hyg 64 1-2 2001 49 55
9. M.K. Hart, K. Caswell-Stephan, and R. Bakken Improved mucosal protection against Venezuelan equine encephalitis virus is induced by the molecularly defined, live-attenuated V3526 vaccine candidate Vaccine 18 26 2000 3067 3075
10. W.D. Pratt, N.L. Davis, R.E. Johnston, and J.F. Smith Genetically engineered, live attenuated vaccines for Venezuelan equine encephalitis: testing in animal models Vaccine 21 25-26 2003 3854 3862
11. M.S. Oberste, M. Fraire, and R. Navarro Association of Venezuelan equine encephalitis virus subtype IE with two equine epizootics in Mexico Am J Trop Med Hyg 59 1 1998 100 107
12. Franck PT. Discussion: round table on epidemic control. In: Proceedings of the Workshop-Symposium on Venezuelan Equine Encephalitis Virus, vol. 243. Washington, DC: Pan American Health Organization; 14-17 September 1971; p. 400.
13. W.H. Dietz Jr., P.H. Peralta, and K.M. Johnson Ten clinical cases of human infection with venezuelan equine encephalomyelitis virus, subtype I-D Am J Trop Med Hyg 28 2 1979 329 334
14. J. De Mucha-Macias, and I. Sanchez-Spindola Two human cases of laboratory infection with Mucambo virus Am J Trop Med Hyg 14 3 1965 475 478
15. D.S. Reed, C.M. Lind, L.J. Sullivan, W.D. Pratt, and M.D. Parker Aerosol infection of cynomolgus macaques with enzootic strains of Venezuelan equine encephalitis viruses J Infect Dis 189 6 2004 1013 1017
16. M.K. Hart, C. Lind, R. Bakken, M. Robertson, R. Tammariello, and G.V. Ludwig Onset and duration of protective immunity to IA/B and IE strains of Venezuelan equine encephalitis virus in vaccinated mice Vaccine 20 2002 616 622
17. Parker MD, Crise B, Oberste S, Lind CM, Smith JF, Hart MK. Attenuation of enzootic VEE by furin cleavage site deletion of a full length cDNA clone, manuscript in preparation.
18. W.F. Scherer, R.W. Dickerman, and J.V. Ordonez Discovery and geographic distribution of Venezuelan encephalitis virus in Guatemala, Honduras, and British Honduras during 1965-68, and its possible movement to Central America and Mexico Am J Trop Med Hyg 19 4 1970 703 711
19. W.D. Pratt, P. Gibbs, M.L. Pitt, and A.L. Schmaljohn Use of telemetry to assess vaccine-induced protection against parenteral and aerosol infections of Venezuelan equine encephalitis virus in non-human primates Vaccine 16 910 1998 1056 1064
20. T.P. Monath, C.B. Cropp, W.F. Short, R.A. Bowen, R.M. Kinney, and J.T. Roehrig Recombinant Vaccinia-Venezuelan equine encephalomyelitis (VEE) vaccine protects nonhuman primates against parenteral and intranasal challenge with virulent VEE virus Vaccine Res 1 1992 55 68
21. A.M. Powers, A.C. Brault, R.M. Kinney, and S.C. Weaver The use of chimeric Venezuelan equine encephalitis viruses as an approach for the molecular identification of natural virulence determinants J Virol 74 9 2000 4258 4263
22. A.L. Schmaljohn, E.D. Johnson, J.M. Dalrymple, and G.A. Cole Non-neutralizing monoclonal antibodies can prevent lethal alphavirus encephalitis Nature 297 5861 1982 70 72
23. L.D. Jones, A.M. Bennett, S.R. Moss, E.A. Gould, and R.J. Phillpotts Cytotoxic T-cell activity is not detectable in Venezuelan equine encephalitis virus-infected mice Virus Res 91 2 2003 255 259
24. J.F. Rowell, and D.E. Griffin Contribution of T cells to mortality in neurovirulent Sindbis virus encephalomyelitis J Neuroimmunol 127 1-2 2002 106 114
25. D. Griffin, B. Levine, W. Tyor, S. Ubol, and P. Despres The role of antibody in recovery from alphavirus encephalitis Immunol Rev 159 1997 155 161